Back to search
FDAFDA · Food and drugs·Recall number Z-0537-2014

Streptex* kit, Ref R30950501 ZL50, Rapid latex test for Streptococcal grouping, IVD. The kit contains reagent groups A, B, C, D, F, G, a control, and an extraction enzyme. The firm name on the label is Remel Europe Ltd., Dartford, England. Streptex is a rapid latex test system for use in the qualitative detection and identification of the Lancefield group of streptococci. Reagents are provided for groups A, B, C, D, F and G covering the majority of clinical isolates, group E streptococci are rarely isolated.

Published December 25, 2013 · Recall initiated: May 2, 2013

Summary

FDA records medical device Class II recall Z-0537-2014, published December 25, 2013 and initiated May 2, 2013. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 768 kits; Lot: Lot 1192181, exp. January 2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The product may give weak or false negative test results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Nationwide Distribution
Lot
Lot 1192181, exp. January 2014
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Streptex* kit, Ref R30950501 ZL50, Rapid latex test for Streptococcal grouping, IVD. The kit contains reagent groups A, B, C, D, F, G, a control, and an extraction enzyme. The firm name on the label is Remel Europe Ltd., Dartford, England. Streptex is a rapid latex test system for use in the qualitative detection and identification of the Lancefield group of streptococci. Reagents are provided for groups A, B, C, D, F and G covering the majority of clinical isolates, group E streptococci are rarely isolated. recalled?

Yes. FDA published recall Z-0537-2014 on December 25, 2013. Reported hazard: The product may give weak or false negative test results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter